The numbers of apps for disease awareness and management are increasing and, with patients more willing to share data with HCPs, there are opportunities to better understand how conditions impact ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Expert Rev Cardiovasc Ther. 2012;10(3):387-395. Patients on bedrest will continue to have OH despite other treatment measures. Time out of bed – at least sitting – is preferred. Exercise and ...